Oscar Health, Inc. $OSCR Shares Sold by Glynn Capital Management LLC

Glynn Capital Management LLC trimmed its position in Oscar Health, Inc. (NYSE:OSCR) by 5.1% during the third quarter, Holdings Channel.com reports. The firm owned 2,856,025 shares of the company’s stock after selling 153,753 shares during the period. Oscar Health accounts for about 17.1% of Glynn Capital Management LLC’s holdings, making the stock its largest holding. Glynn Capital Management LLC’s holdings in Oscar Health were worth $54,065,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. acquired a new stake in Oscar Health during the first quarter worth approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Oscar Health by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock worth $2,827,000 after acquiring an additional 8,879 shares during the period. Jones Financial Companies Lllp raised its holdings in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Oscar Health by 39.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after purchasing an additional 132,149 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

NYSE OSCR opened at $13.98 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.96. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.80. The firm has a market capitalization of $4.16 billion, a P/E ratio of -8.03 and a beta of 1.90. The business’s 50-day simple moving average is $14.70 and its 200-day simple moving average is $16.63.

Oscar Health (NYSE:OSCR) last posted its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). The business had revenue of $2.81 billion for the quarter, compared to analyst estimates of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The firm’s revenue for the quarter was up 17.3% compared to the same quarter last year. During the same period last year, the company posted ($0.62) EPS. Equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Activity

In other news, insider Mario Schlosser sold 23,038 shares of the firm’s stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total value of $406,620.70. Following the transaction, the insider owned 350,180 shares of the company’s stock, valued at approximately $6,180,677. This trade represents a 6.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders have sold a total of 138,835 shares of company stock valued at $2,298,269 over the last ninety days. 24.39% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have recently commented on OSCR. UBS Group reaffirmed a “neutral” rating and issued a $15.00 price objective on shares of Oscar Health in a research report on Wednesday, February 11th. Wall Street Zen upgraded Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. Stephens initiated coverage on shares of Oscar Health in a research note on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price objective for the company. Barclays set a $18.00 target price on shares of Oscar Health and gave the stock an “equal weight” rating in a research report on Monday, January 5th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $16.88.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.